News

Merck and Parexel said that under the contract, a Merck BioVentures unit will be established within the Parexel organization. Parexel chairman and CEO Josef von Rickenbach said they

Most recently, Devlin worked as the vice president of Abbott where she led Global Pipeline Marketing for all therapeutic areas, including oncology. Devlin held positions as vice president

As per the terms of the agreement, Nycomed is expected to take up the responsibility of marketing and distributing Zenpep (pancrelipase) delayed-Release capsules in Russia and CIS, as

In the trial, the company has involved patients previously treated with locally advanced or metastatic, non-squamous non-small cell lung cancer (NSCLC) who will receive ARQ 197 plus erlotinib

Under the agreement, SCRI will partner with AstraZeneca to provide clinical programme development expertise, clinical programme design, medical oversight and trial management. The first clinical trial to be

AACL is a provider of analytical testing and research services to companies that develops, produces and distributes nutritional supplements, nutraceuticals, pharmaceuticals and biopharmaceuticals. AACL offers clients to evaluate

The primary objective of the study is to establish the maximum tolerated dose of daily oral BMN 673. However, the secondary objectives are to evaluate the safety, tolerability,

In addition to receiving an upfront payment of $1m, which includes $500,000 in cash and $500,000 in equity shares at a 50% premium investment, Dyax is eligible for

The analysed drugs include Pfizer’s Celebrex, Merck’s Vioxx, Novartis’s Prexige, the experimental etoricoxib, ibuprofen, and diclofenac. Naproxen and Ibuprofen (sold as Advil) were found to be the least